- Home
- KEY vs WST Comparison
KEY vs WST Comparison
Compare KEY & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEY
- WST
- Stock Information
- Founded
- KEY 1825
- WST 1923
- Country
- KEY United States
- WST United States
- Employees
- KEY N/A
- WST N/A
- Industry
- KEY Major Banks
- WST Medical/Dental Instruments
- Sector
- KEY Finance
- WST Health Care
- Exchange
- KEY Nasdaq
- WST Nasdaq
- Market Cap
- KEY 20.8B
- WST 18.9B
- IPO Year
- KEY N/A
- WST N/A
- Fundamental
- Price
- KEY $19.10
- WST $255.71
- Analyst Decision
- KEY Buy
- WST Buy
- Analyst Count
- KEY 16
- WST 7
- Target Price
- KEY $19.72
- WST $332.50
- AVG Volume (30 Days)
- KEY 27.3M
- WST 534.5K
- Earning Date
- KEY 10-16-2025
- WST 10-23-2025
- Dividend Yield
- KEY 4.28%
- WST 0.33%
- EPS Growth
- KEY N/A
- WST N/A
- EPS
- KEY 0.03
- WST 6.68
- Revenue
- KEY $4,743,000,000.00
- WST $2,960,200,000.00
- Revenue This Year
- KEY $76.36
- WST $6.28
- Revenue Next Year
- KEY $6.10
- WST $6.02
- P/E Ratio
- KEY $600.01
- WST $39.45
- Revenue Growth
- KEY N/A
- WST 2.90
- 52 Week Low
- KEY $12.73
- WST $187.43
- 52 Week High
- KEY $20.04
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- KEY 57.55
- WST 60.82
- Support Level
- KEY $18.65
- WST $249.94
- Resistance Level
- KEY $19.35
- WST $264.06
- Average True Range (ATR)
- KEY 0.33
- WST 5.38
- MACD
- KEY -0.02
- WST 0.92
- Stochastic Oscillator
- KEY 49.82
- WST 70.96
About KEY KeyCorp
With assets of around $185 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.